TRACY ALJABI: Open Payments
NPI 1568092013 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,266 in 116 payments from 18 companies in 2025. Trend: 2023 $1,797 · 2024 $1,448 · 2025 $2,266
Food & beverage: $2,266
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 14 | $320 |
| Neurelis, Inc. | 14 | $301 |
| Eisai Inc. | 7 | $263 |
| Lundbeck LLC | 16 | $235 |
| PFIZER INC. | 16 | $219 |
| ABBVIE INC. | 13 | $205 |
| SK Life Science, Inc. | 5 | $137 |
| Lilly USA, LLC | 8 | $119 |
| Novartis Pharmaceuticals Corporation | 5 | $96 |
| Biogen, Inc. | 3 | $71 |
Products named: LEQEMBI, VALTOCO, Fintepla, NURTEC ODT, VYEPTI, QULIPTA, AMYVID, KESIMPTA.
Industry payments across LA — which companies pay providers there.
